Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram‐Positive Bacteria
Author(s):
David M.P. De Oliveira, Bernhard Keller, Andrew J. Hayes, Cheryl Lynn Y. Ong, Nichaela Harbison‐price, Ibrahim M. El‐deeb, Gen Li, Nadia Keller, Lisa Bohlmann, Stephan Brouwer, Andrew G. Turner, Amanda J. Cork, Thomas R. Jones, David L. Paterson, Alastair G. McEwan, Mark R. Davies, Christopher A. McDevitt, Mark von Itzstein, Mark J. Walker
Details:
Antibiotics, Volume 11, Issue 4, 2022-04-01, Article number 449
Article Link: Click here
Affiliations:
- The University of Queensland
- Griffith University
- Department of Microbiology & Immunology
- UQ Centre for Clinical Research

